metastatic triple-negative breast cancer

AstraZeneca-Daiichi Sankyo’s therapy shows response in breast cancer trials
Clinical Trials Arena
Mon, 12/12/22 - 10:26 am
AstraZeneca
Daiichi Sankyo
clinical trials
datopotamab deruxtecan
metastatic triple-negative breast cancer
breast cancer
Troubled Immunomedics tries again at FDA after rejection
Fierce Biotech
Thu, 12/5/19 - 10:07 am
Immunomedics
IMMU-132
sacituzumab govitecan
FDA
metastatic triple-negative breast cancer
After FDA rejection, Immunomedics tries again with breast cancer drug
Biopharma Dive
Tue, 12/3/19 - 10:23 pm
Immunomedics
breast cancer
sacituzumab govitecan
metastatic triple-negative breast cancer
FDA
Roche's ipatasertib-Tecentriq combo leads to 73% ORR in TNBC patients
BioCentury
Mon, 04/1/19 - 09:32 pm
Roche
clinical trials
Ipatasertib
metastatic triple-negative breast cancer
AACR